Supp. Figure 1 MM-302 trastuzumab Vessels Hoechst Merge
* p = 0.0189 * p = 0.0101 Supp. Figure 2 16 12 Percent injected dox/gram tissue MM-302 + IgG MM-302 + T-DM1 PBS trastuzumab alone 16 12 4 * p = 0.0189 8 * p = 0.0101
time following injection (hrs) Supp. Figure 3 MM-302 (3 mg/kg) MM-302 + trastuzumab ng dox/5mL plasma (log) time following injection (hrs)
Supp. Figure 4 BT474-M3 NCI-N87 MM-302 + trast. Bliss additive value MM-302 alone trastuzumab alone Time following first dose (days) BT474-M3 NCI-N87 % tumor growth inhibition 100 80 60 40 20 5 10 15 25 30 35